Chinook Therapeutics stock surges on deal to be bought for up to $3.5 billion by NovartisMarket Watch • 06/12/23
Novartis bolsters innovative medicines strategy and renal pipeline with agreement to acquire Chinook Therapeutics for USD 3.2bn upfront (USD 40 / share)GlobeNewsWire • 06/12/23
Novartis Kisqali® significantly reduced the risk of recurrence by 25% across a broad population of patients with early breast cancer; clinically meaningful benefit was consistent across subgroupsGlobeNewsWire • 06/02/23
Sandoz plans move to new central Basel headquarters by mid-2024, following proposed spin-off as standalone companyGlobeNewsWire • 06/01/23